Literature DB >> 1313013

Permissible amino acid substitutions within the putative nucleoside binding site of herpes simplex virus type 1 encoded thymidine kinase established by random sequence mutagenesis [corrected].

K M Munir1, D C French, D K Dube, L A Loeb.   

Abstract

We determined the essentiality of all amino acid replacements within an 11-codon sequence in the putative nucleoside-binding site of thymidine kinase encoded by herpes simplex virus type 1. This involved partial randomization of 11 codons in the gene to create a degenerate library, followed by genetic complementation using a tk- Escherichia coli strain and selection of unnatural active enzymes. We produced and tested 53,000 variants; of which 190 were found to be biologically active. Sequence analyses of functional variants revealed a high degree of flexibility in accommodating different types of amino acid substitutions in this region. However, no replacement was tolerated at proline-173, whereas tyrosine-172 could be replaced by only phenylalanine. To further define permissible substitutions at specified positions, we constructed a library with randomization at only four test codons. We produced and tested 600,000 variants; of which only 5 were active. Again proline-173 was conserved, and only tyrosine and phenylalanine were found at position 172. The identification of these conserved amino acids should provide important insights into the understanding of the structural basis of catalysis by this enzyme.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313013

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Replication fidelity of the supF gene integrated in the thymidine kinase locus of herpes simplex virus type 1.

Authors:  Ying T Hwang; Bu-Yuan Liu; Charles B C Hwang
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Mutation spectra of herpes simplex virus type 1 thymidine kinase mutants.

Authors:  Qiaosheng Lu; Ying T Hwang; Charles B C Hwang
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Cloning and expression of human deoxyguanosine kinase cDNA.

Authors:  M Johansson; A Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

4.  Exploring the active site of chorismate mutase by combinatorial mutagenesis and selection: the importance of electrostatic catalysis.

Authors:  P Kast; M Asif-Ullah; N Jiang; D Hilvert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 5.  In vivo versus in vitro screening or selection for catalytic activity in enzymes and abzymes.

Authors:  J Fastrez
Journal:  Mol Biotechnol       Date:  1997-02       Impact factor: 2.695

6.  Tolerance of different proteins for amino acid diversity.

Authors:  M Suzuki; F C Christians; B Kim; A Skandalis; M E Black; L A Loeb
Journal:  Mol Divers       Date:  1996-10       Impact factor: 2.943

7.  Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.

Authors:  M E Black; T G Newcomb; H M Wilson; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

8.  Combinatorial libraries by cassette mutagenesis.

Authors:  B Borrego; A Wienecke; A Schwienhorst
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

9.  A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant.

Authors:  C B Hwang; B Horsburgh; E Pelosi; S Roberts; P Digard; D M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

10.  Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells.

Authors:  M F Chan; R van Amerongen; T Nijjar; E Cuppen; P A Jones; P W Laird
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.